Collaborative study on the 1st international reference panel (plasma) for lupus anticoagulant
WHO Expert Committee on Biological Standardization & World Health Organization. (2014). Collaborative study on the 1st international reference panel (plasma) for lupus anticoagulant. World Health Organization. http://www.who.int/iris/handle/10665/137474
Gov't Doc #WHO/BS/2014.2244
MetadataShow full item record
Showing items related by title and MeSH subject.
Report on a collaborative study for proposed 1st WHO international standard for Lupus (anti-dsDNA) antibodies (15/174) World Health Organization; WHO Expert Committee on Biological Standardization; Adrian Bristow; Bernard Fox; Carl Dolman; Susan J Thorpe; Peter Rigsby; Jason Hockley; Johan Rönnelid; Pier Luigi Meroni (WHO/BS/2017.2306, 2017)
Tazi, I.; Fehri, S.; Elghrari, K.; Ouazzani, T.; Benchemsi, N. (2009)We determined the prevalence of antibodies to Epstein-Barr virus [EBV] in 44 patients with systemic lupus erythematosus [SLE] and 44 healthy blood donors matched for sex and age as controls. Of the cases, 39 were women; mean age was 33 years. Four cases [9%] and 5 controls [11%] were positive for IgM anti-viral capsid antigen [VCA] [P = 0.9]. All the cases were positive for IgG anti-VCA compared with 91% of the controls [P = 0.12]. The mean immunity ratio for this antibody was 2.341 in cases and 1.873 in controls [P = 0.068]. Forty [91%] cases ...